"Clinical Research Studies in multiple therapeutic areas, including diabetes type 1 and 2, kidney disease, migraines, osteoarthritis, obesity, IBS, and vaccines."

During the past decade, Chase Medical Research, LLC conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 41 clinical trials were completed, i.e. on average, 85.4% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 24 clinical trials were completed. i.e. 96% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chase Medical Research, LLC" #1 sponsor was "Eli Lilly and Company" with 17 trials, followed by "Pfizer" with 6 trials sponsored, "Bayer" with 3 trials sponsored, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials sponsored and "Mannkind Corporation" with 3 trials sponsored. Other sponsors include 45 different institutions and companies that sponsored additional 44 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chase Medical Research, LLC" #1 collaborator was "Pfizer" with 4 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Allergan Sales, LLC" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator and "CoLucid Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Chase Medical Research, LLC" are "Type 2 Diabetes Mellitus" (9 trials), "Type 2 Diabetes" (8 trials), "Alzheimer's Disease" (5 trials), "Diabetes Mellitus, Type 2" (5 trials) and "Migraine" (5 trials). Many other conditions were trialed in "Chase Medical Research, LLC" in a lesser frequency.

Most popular intervention types in "Chase Medical Research, LLC" are "Drug" (76 trials), "Biological" (5 trials), "Other" (5 trials), "Behavioral" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (35 trials), "Tirzepatide" (6 trials), "Dulaglutide" (5 trials), "Insulin Degludec" (4 trials) and "placebo" (4 trials). Other intervention names were less common.

The vast majority of trials in "Chase Medical Research, LLC" are 74 trials for "All" genders, 7 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Chase Medical Research, LLC". undefined are not yet recruiting, 9 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 59 completed trials in Chase Medical Research, LLC, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Chase Medical Research, LLC, 0 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 50 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 2 trials that are defined as “Not Applicable".